Dr Ahmed Alaskar is executive director of the King Abdullah International Medical Research Center (KAIMRC); president of the Saudi Society of Blood and Marrow Transplantation (SSBMT); professor of Consultant Adult Hematology & HSCT at King Saud bin Abdulaziz University for Health Sciences; and chairman of the Riyadh Global Medical Biotechnology Summit 2021. Here, Dr Alaskar presents what Saudi Arabia has to offer as a research investment destination, the work of KAIMRC, and its role in paving Saudi’s road to becoming a global clinical trials hub.
Vision 2030 is creating greater stakeholder alignment, and making Saudi Arabia a more attractive destination for pharma industry investment, especially in clinical trials at this stage, where we have strong clinical capabilities
